February 2025 Stock Picks: Insights and Considerations
The stock market has experienced some ups and downs this January. However, remember—it’s not about the market as a whole, but rather about the individual stocks. Opportunities still exist.
In this article, we will focus on five top stocks to consider buying this upcoming February. Among these is Meta Platforms (NASDAQ: META). Exciting developments from the Chinese company DeepSeek suggest that artificial intelligence technology may soon become more affordable, which could benefit Meta significantly.
Where should you invest $1,000 today? Our analysts have highlighted the 10 best stocks to consider for immediate investment. Discover the 10 stocks »
For more details, watch the video below, subscribe to our channel, and explore the exclusive offer linked within.
*Stock prices referenced are based on end-of-day values from January 27, 2025. The video is dated January 28, 2025.
Is Now the Right Time to Invest in Meta Platforms?
Before making an investment in Meta Platforms, there are some important factors to consider:
The Motley Fool Stock Advisor analyst team recently identified what they believe are the 10 best stocks to buy now—and notably, Meta Platforms was not included in that list. The selected stocks could deliver remarkable returns in the years ahead.
For context, consider when Nvidia was featured on this list back on April 15, 2005. If you had invested $1,000 based on that recommendation, your investment would be worth $763,921 today!*
Stock Advisor offers investors a straightforward strategy for success, complete with portfolio-building guidance, regular analyst updates, and two new stock picks each month. Since its inception in 2002, the Stock Advisor service has delivered returns more than four times greater than those of the S&P 500 index*
Learn more »
*Stock Advisor returns as of January 27, 2025
Randi Zuckerberg, who previously directed market development at Facebook and is the sister of Meta Platforms CEO Mark Zuckerberg, serves on The Motley Fool’s board. Mark Roussin, CPA, holds positions in AbbVie. The Motley Fool has recommended AbbVie, Merck, and Meta Platforms, but also suggests Stag Industrial. The Motley Fool has a disclosure policy regarding its affiliations. Mark Roussin is associated with The Motley Fool and may receive compensation for promoting their services. Subscribing through their link may provide them with additional funds to support their channel. All opinions presented are their own and are not influenced by The Motley Fool.
The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Nasdaq, Inc.
